Behavioral health insurance parity for federal employees.

PubWeight™: 3.77‹?› | Rank: Top 1%

🔗 View Article (PMID 16571881)

Published in N Engl J Med on March 30, 2006

Authors

Howard H Goldman1, Richard G Frank, M Audrey Burnam, Haiden A Huskamp, M Susan Ridgely, Sharon-Lise T Normand, Alexander S Young, Colleen L Barry, Vanessa Azzone, Alisa B Busch, Susan T Azrin, Garrett Moran, Carolyn Lichtenstein, Margaret Blasinsky

Author Affiliations

1: University of Maryland School of Medicine, Baltimore, MD 21227, USA. hh.goldman@verizon.net

Articles citing this

Behavioral health insurance parity: does Oregon's experience presage the national experience with the Mental Health Parity and Addiction Equity Act? Am J Psychiatry (2011) 2.24

A political history of federal mental health and addiction insurance parity. Milbank Q (2010) 1.70

Insurance parity and the use of outpatient mental health care following a psychiatric hospitalization. JAMA (2008) 1.48

The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. Am J Psychiatry (2013) 1.34

Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics (2007) 1.33

Effect of insurance parity on substance abuse treatment. Psychiatr Serv (2011) 1.23

Do state parity laws reduce the financial burden on families of children with mental health care needs? Health Serv Res (2007) 1.19

Why We Should Not Be Indifferent to Specification Choices for Difference-in-Differences. Health Serv Res (2014) 1.15

The effects of federal parity on substance use disorder treatment. Am J Manag Care (2014) 1.13

Benefit limits for behavioral health care in private health plans. Adm Policy Ment Health (2008) 1.10

A bayesian two-part latent class model for longitudinal medical expenditure data: assessing the impact of mental health and substance abuse parity. Biometrics (2011) 0.99

Health Plans' Early Response to Federal Parity Legislation for Mental Health and Addiction Services. Psychiatr Serv (2015) 0.98

12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug Alcohol Depend (2012) 0.91

Economic benefits of intensive insulin therapy in critically Ill patients: the targeted insulin therapy to improve hospital outcomes (TRIUMPH) project. Diabetes Care (2008) 0.90

Effects of Global Payment and Accountable Care on Tobacco Cessation Service Use: An Observational Study. J Gen Intern Med (2016) 0.87

Federal parity law associated with increased probability of using out-of-network substance use disorder treatment services. Health Aff (Millwood) (2015) 0.86

What Oregon's parity law can tell us about the federal Mental Health Parity and Addiction Equity Act and spending on substance abuse treatment services. Drug Alcohol Depend (2012) 0.85

The effect of parity on expenditures for individuals with severe mental illness. Health Serv Res (2013) 0.83

The effect of comprehensive behavioral health parity on choice of provider. Med Care (2012) 0.82

Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research: An Observational Study of the Effectiveness of Mental Health Parity. Stat Biosci (2011) 0.82

Effect of the Low Risk Ankle Rule on the frequency of radiography in children with ankle injuries. CMAJ (2013) 0.82

Economic grand rounds: the price is right? Changes in the quantity of services used and prices paid in response to parity. Psychiatr Serv (2012) 0.82

From research to health policy impact. Health Serv Res (2012) 0.81

The Early Impact Of The 'Alternative Quality Contract' On Mental Health Service Use And Spending In Massachusetts. Health Aff (Millwood) (2015) 0.80

Implications of the Mental Health Parity and Addiction Equity Act. Am J Psychiatry (2012) 0.80

Behavioral health parity and the Affordable Care Act. J Soc Work Disabil Rehabil (2014) 0.78

Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation. J Interv Card Electrophysiol (2012) 0.78

Parity and out-of-pocket spending for children with high mental health or substance abuse expenditures. Pediatrics (2013) 0.77

Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors. Clin Ther (2015) 0.77

Legislations and policies to expand mental health and substance abuse benefits in health insurance plans: a community guide systematic economic review. J Ment Health Policy Econ (2015) 0.76

Better behavioral health care coverage for everyone. N Engl J Med (2006) 0.76

The effectiveness of interventions to reduce the household economic burden of illness and injury: a systematic review. Bull World Health Organ (2014) 0.76

The interdependence of behavioral and somatic health: implications for conceptualizing health and measuring treatment outcomes. Int J Integr Care (2007) 0.75

Private Health Plans' Contracts with Managed Behavioral Healthcare Organizations. J Behav Health Serv Res (2015) 0.75

The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral health utilization and expenditures among "carve-out" enrollees. J Health Econ (2016) 0.75

Parity: an ongoing challenge and research opportunity. Am J Psychiatry (2013) 0.75

Effects of accountable care and payment reform on substance use disorder treatment: evidence from the initial 3 years of the alternative quality contract. Addiction (2016) 0.75

Addressing public stigma and disparities among persons with mental illness: the role of federal policy. Am J Public Health (2013) 0.75

Benefits Improvement and Protection Act's impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal disease. Transplantation (2013) 0.75

Changes in Characteristics and Practice Patterns of Ontario Psychiatrists. Can J Psychiatry (2016) 0.75

Effects of mental health benefits legislation: a community guide systematic review. Am J Prev Med (2015) 0.75

Behavioral health services in separate CHIP programs on the eve of parity. Adm Policy Ment Health (2012) 0.75

Effect of copayments on use of outpatient mental health services among elderly managed care enrollees. Med Care (2011) 0.75

The Effects of the Transition From Medicaid to Medicare on Health Care Use for Adults With Mental Illness. Med Care (2016) 0.75

The Mental Health Parity and Addiction Equity Act (MHPAEA) Evaluation Study: Impact on Quantitative Treatment Limits. Psychiatr Serv (2016) 0.75

Medicaid lapses and low-income young adults' receipt of outpatient mental health care after an inpatient stay. Psychiatr Serv (2014) 0.75

Heterogeneity and the effect of mental health parity mandates on the labor market. J Health Econ (2015) 0.75

Articles by these authors

Screening for serious mental illness in the general population. Arch Gen Psychiatry (2003) 15.75

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54

Promotion of prescription drugs to consumers. N Engl J Med (2002) 9.21

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00

Early experience with pay-for-performance: from concept to practice. JAMA (2005) 8.98

Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med (2005) 8.52

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med (2003) 7.28

Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46

An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00

Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes (2009) 5.66

Pay for performance in commercial HMOs. N Engl J Med (2006) 5.52

An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation (2006) 5.35

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16

Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06

Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation (2007) 4.74

An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation (2006) 4.52

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39

Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36

Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24

Physician clinical performance assessment: prospects and barriers. JAMA (2003) 4.16

Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95

Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ (2005) 3.94

Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med (2003) 3.81

Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71

The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol (2002) 3.71

Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol (2013) 3.70

Variability in the measurement of hospital-wide mortality rates. N Engl J Med (2010) 3.65

Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45

Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation (2005) 3.38

The effect of malpractice reform on emergency department care. N Engl J Med (2014) 3.33

Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Circulation (2010) 3.32

An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2011) 3.31

Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease. Circulation (2013) 3.30

Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med (2008) 3.29

Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study. Stat Med (2007) 3.20

Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv (2002) 3.15

What is the empirical basis for paying for quality in health care? Med Care Res Rev (2006) 3.11

Nonemergency PCI at hospitals with or without on-site cardiac surgery. N Engl J Med (2013) 2.98

Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med (2009) 2.96

Informatics systems to promote improved care for chronic illness: a literature review. J Am Med Inform Assoc (2007) 2.76

Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ (2006) 2.71

Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement. Health Aff (Millwood) (2007) 2.62

Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection. Ann Thorac Surg (2007) 2.60

Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating. Ann Thorac Surg (2007) 2.59

Regionalization and the underuse of angiography in the Veterans Affairs Health Care System as compared with a fee-for-service system. N Engl J Med (2003) 2.57

Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation (2007) 2.55

Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol (2009) 2.45

Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ (2005) 2.43

Massachusetts cardiac surgery report card: implications of statistical methodology. Ann Thorac Surg (2005) 2.40

New estimates of drug development costs. J Health Econ (2003) 2.33

National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes (2010) 2.33

Gun policy and serious mental illness: priorities for future research and policy. Psychiatr Serv (2014) 2.26

Behavioral health insurance parity: does Oregon's experience presage the national experience with the Mental Health Parity and Addiction Equity Act? Am J Psychiatry (2011) 2.24

An administrative claims model for profiling hospital 30-day mortality rates for pneumonia patients. PLoS One (2011) 2.22

Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med (2003) 2.21

Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med (2010) 2.20

Moving beyond parity--mental health and addiction care under the ACA. N Engl J Med (2011) 2.20

The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for medicare beneficiaries with pneumonia. J Hosp Med (2010) 2.20

The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 2.18

Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. Am J Med (2004) 2.15

National trends in outcomes among elderly patients with heart failure. Am J Med (2006) 2.13

ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation (2006) 2.12

American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Circulation (2005) 2.10

Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med (2011) 2.09

End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08

Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA (2013) 2.06

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J (2010) 2.00

Specialty care medical homes for people with severe, persistent mental disorders. Health Aff (Millwood) (2010) 1.99

Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99

"America's Best Hospitals" in the treatment of acute myocardial infarction. Arch Intern Med (2007) 1.96

Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation (2004) 1.96

The PROMETHEUS bundled payment experiment: slow start shows problems in implementing new payment models. Health Aff (Millwood) (2011) 1.96

Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95

"Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol (2004) 1.94

Getting the methods right--the foundation of patient-centered outcomes research. N Engl J Med (2012) 1.92

Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care (2012) 1.91

Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials. Biometrics (2005) 1.91

Design of mental health benefits: still unequal after all these years. Health Aff (Millwood) (2003) 1.90

Comparison of hospital risk-standardized mortality rates calculated by using in-hospital and 30-day models: an observational study with implications for hospital profiling. Ann Intern Med (2012) 1.90

ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation (2005) 1.90

Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med (2012) 1.89

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ (2005) 1.84

Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care (2004) 1.84

Interdisciplinary staffing patterns: do for-profit and nonprofit hospices differ? J Palliat Med (2010) 1.84

Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry. J Am Coll Cardiol (2011) 1.84

New Jersey's efforts to improve postpartum depression care did not change treatment patterns for women on medicaid. Health Aff (Millwood) (2011) 1.83

Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA (2010) 1.83

Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc (2005) 1.82

Impact of hospice disenrollment on health care use and medicare expenditures for patients with cancer. J Clin Oncol (2010) 1.81

Performance measurement in the small office practice: challenges and potential solutions. Ann Intern Med (2008) 1.80

Longitudinal profiling of health care units based on continuous and discrete patient outcomes. Biostatistics (2005) 1.79

Cognition and take-up of subsidized drug benefits by Medicare beneficiaries. JAMA Intern Med (2013) 1.79

Comparison of "risk-adjusted" hospital outcomes. Circulation (2008) 1.78

ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol (2005) 1.76

The volume-outcome relationship: from Luft to Leapfrog. Ann Thorac Surg (2003) 1.76